Angiocrine Bioscience, Inc. – Trademark Portfolio

Entity Type: 03

Angiocrine Bioscience, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include E-CEL, E-CEL UVEC, E-CELERATE, and ANGIOCRINE BIOSCIENCE. The owner is based in San Diego, CA.

11575 Sorrento Valley Road, Suite 217

San Diego, CA 92121

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Angiocrine Bioscience, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Angiocrine Bioscience, Inc. have?

Angiocrine Bioscience, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Angiocrine Bioscience, Inc. file in?

Angiocrine Bioscience, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Angiocrine Bioscience, Inc.'s most well-known trademarks?

Angiocrine Bioscience, Inc.'s registered trademark portfolio includes well-known marks such as E-CEL, E-CEL UVEC, E-CELERATE, and ANGIOCRINE BIOSCIENCE. These are among 4 currently registered trademarks in the portfolio.

What is Angiocrine Bioscience, Inc.'s trademark registration success rate?

Angiocrine Bioscience, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.